Endocrine Abstracts

Background: Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognised disorder with an estimated prevalence of 20–30% in the general population and is considered as the hepatic manifestation of the metabolic syndrome. Fatty liver index (FLI) has been developed as an indicator of hepatic steatosis (HS). Another marker, the lipid accumulation product (LAP) index, initially developed to assess cardiovascular risk, has been recently shown to be a reliable marker ...

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinopathy in women of reproductive age and is characterized by chronic anovulation and clinical and/or biochemical hyperandrogenism. Chronic autoimmune thyroiditis (AIT) is a common disease of organ-specific autoimmunity affecting predominantly women, that is attributed to an interaction between a genetic background and environmental factors. There are few data showing higher AIT prevalence in PCOS patients.<p...

Background: Increased prevalence of abnormal aminotransferase levels and/or ultrasonographic evidence of hepatic steatosis have been found in women with polycystic ovary syndrome (PCOS), being more pronounced in overweight and obese patients. However, few data exist concerning the prevalence of PCOS in premenopausal women with nonalcoholic fatty liver disease (NAFLD).Objective: To investigate the presence of PCOS in overweight and obese premenopausal wom...